Trial Profile
Non-interventional study in patients with peripheral or central neuropathic pain undergoing symptomathic treatment with Lyrica [pregabalin]
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 25 Jan 2021
Price :
$35
*
At a glance
- Drugs Pregabalin (Primary)
- Indications Neuropathic pain
- Focus Therapeutic Use
- Sponsors Pfizer
- 25 Sep 2008 Actual study completion date changed from Nov 2007 to Dec 2007 as reported by ClinicalTrials.gov.
- 25 Sep 2008 Actual patient number (746) added as reported by ClinicalTrials.gov.
- 03 Mar 2008 Status changed from recruiting to completed as reported by ClinicalTrials.gov.